BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36206112)

  • 1. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
    Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
    Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
    Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
    Yang L; Wang L; Wu J; Wang Y
    Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
    Luo H; Peng J; Yuan Y
    Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
    Cai Y; Dong Z; Wang J
    World J Surg Oncol; 2022 Oct; 20(1):329. PubMed ID: 36192755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
    Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
    Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101.
    Sun Z; Zhang S; Zhang N; Wang J; Wang J; Liu J
    Thorac Cancer; 2022 Jun; 13(12):1751-1762. PubMed ID: 35524161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
    Wang J; Yang K; Cao J; Li L
    Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
    Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
    Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA PDE3B regulates tumorigenicity via the miR-136-5p/MAP3K2 axis of esophageal squamous cell carcinoma.
    Yue W; Ye Y; Chen B; Wu D; Wang H; Hui G
    Histol Histopathol; 2023 Sep; 38(9):1029-1041. PubMed ID: 36533720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0006168 Promotes the Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells via miR-516b-5p-Dependent Regulation of XBP1.
    Huang Y; Jiang L; Wei G
    Onco Targets Ther; 2021; 14():2475-2488. PubMed ID: 33883902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0003602 Contributes to the Progression of Colorectal Cancer by Mediating the miR-149-5p/SLC38A1 Axis.
    Wu R; Tang S; Wang Q; Kong P; Liu F
    Gut Liver; 2023 Mar; 17(2):267-279. PubMed ID: 36148577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis.
    Qian CJ; Tong YY; Wang YC; Teng XS; Yao J
    J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA circ-OGDH (hsa_circ_0003340) Acts as a ceRNA to Regulate Glutamine Metabolism and Esophageal Squamous Cell Carcinoma Progression by the miR-615-5p/PDX1 Axis.
    Liang Z; Zhao B; Hou J; Zheng J; Xin G
    Cancer Manag Res; 2021; 13():3041-3053. PubMed ID: 33854374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ-FNDC3B Functions as an Oncogenic Factor in Esophageal Squamous Cell Carcinoma via Upregulating MYO5A by Absorbing miR-136-5p and miR-370-3p.
    Zhang Y; Xiong W; Yang C; Li P; Tong H
    Biochem Genet; 2023 Oct; 61(5):1917-1936. PubMed ID: 36884165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA Circ_0001777 Suppresses Lung Adenocarcinoma Progression In Vitro and In Vivo.
    Zhu L; Liu Y; Tang H; Wang P
    Biochem Genet; 2023 Apr; 61(2):704-724. PubMed ID: 36103059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-ATIC Serves as a Sponge of miR-326 to Accelerate Esophageal Squamous Cell Carcinoma Progression by Targeting ID1.
    Zhang B; Chu W; Li Z; Zhang Y; Zhen Q; Lv B; Liu J; Lu C; Zhao X
    Biochem Genet; 2022 Oct; 60(5):1585-1600. PubMed ID: 35064360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA circ_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis.
    Yang G; Zhang Y; Lin H; Liu J; Huang S; Zhong W; Peng C; Du L
    Bioengineered; 2022 Apr; 13(4):10578-10593. PubMed ID: 35440286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.